Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy-Reference-Cited by-同舟云学术

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Published:2004-01 Issue:2 Volume:18 Page:227-235
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Violin Michela,Cozzi-Lepri Alessandro,Velleca Rossella,Vincenti Antonella,D'Elia Salvatore,Chiodo Francesco,Ghinelli Florio,Bertoli Ada,Monforte Antonella d'Arminio,Perno Carlo Federico,Moroni Mauro,Balotta Claudia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy

2. Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)

3. Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.

4. Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance Trends of Antiretroviral Agents in People with Human Immunodeficiency Virus in Korea, 2012 - 2020;Infection & Chemotherapy;2023

2. Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019;Open Forum Infectious Diseases;2022-04-12

3. A Case of in utero Transmission of Drug-resistant HIV in the United States;Pediatric Infectious Disease Journal;2021-09-07

4. The crosstalk between antiretrovirals pharmacology and HIV drug resistance;Expert Review of Clinical Pharmacology;2020-06-30

5. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort;PLOS ONE;2019-01-16